The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShoe Zone Regulatory News (SHOE)

Share Price Information for Shoe Zone (SHOE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 180.00
Bid: 175.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.714%)
Open: 180.00
High: 180.00
Low: 180.00
Prev. Close: 180.00
SHOE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to AIM and First Day of Dealings

23 May 2014 07:52

RNS Number : 9029H
Shoe Zone PLC
23 May 2014
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

For immediate release

23 May 2014

 

Shoe Zone plc

 

Admission to AIM and First Day of Dealings

 

Shoe Zone plc ("Shoe Zone" or the "Company"), a leading UK specialist value footwear retailer, is pleased to announce that admission will take place and dealings in its ordinary shares will commence at 08:00am today on the AIM market of the London Stock Exchange plc under the ticker SHOE.

 

Copies of the Admission Document are available free of charge during normal business hours at the offices of the Company at Humberstone Road, Leicester, LE1 2LH and at www.shoezoneplc.com.

 

 

For further information please call:

 

Shoe Zone plc

Tel: +44 (0) 116 222 3000

Anthony Smith (CEO)

Charles Smith (COO)

Nick Davis (CFO)

 

Numis Securities Limited (Nominated Adviser & Broker)

Tel: +44 (0) 20 7260 1000

Oliver Cardigan

Alex Ham

Mark Lander

Huw Jeremy

 

FTI Consulting (Financial PR)

Tel: +44 (0) 20 3727 1000

Jonathon Brill

Alex Beagley

Eleanor Purdon

 

Important Notices

Neither this announcement nor any copy of it may be taken or transmitted, published or distributed, directly or indirectly, in, into or from the United States of America (including its territories and possessions, any state of the United States and the District of Columbia (the "United States" or the "US")), Australia, Canada, Japan or South Africa or to any persons in any of those jurisdictions or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction (each a "Restricted Jurisdiction"). Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws.

This announcement does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any shares or other securities in any Restricted Jurisdiction. The Placing and the distribution of this announcement and other information in connection with the Placing and Admission in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Neither this announcement nor any part of it nor the fact of its distribution shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

This announcement is directed only at persons whose ordinary activities involve them in acquiring, holding, managing and disposing of investments (as principal or agent) for the purposes of their business and who have professional experience in matters relating to investments and are: (i) if in a member state of the European Economic Area, qualified investors within the meaning of article 2(1)(e) of the Prospectus Directive ("Qualified Investors"); or (ii) if in the United Kingdom, Qualified Investors and fall within: (a) article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (b) article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Order (all such persons together being referred to as "Relevant Persons"). The term "Prospectus Directive" means Directive 2003/71/EC as amended and includes any relevant implementing measures in each member state of the European Economic Area.

This announcement must not be acted on or relied on by persons who are not Relevant Persons. Persons distributing this announcement must satisfy themselves that it is lawful to do so. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. This announcement does not itself constitute an offer for sale or subscription of any securities in Shoe Zone plc.

The Ordinary Shares referred to in this Announcement have not been and will not be registered under the United States Securities Act of 1933, as amended (the "US Securities Act") or under the securities laws of any state or other jurisdiction of the United States, and may not be offered, sold or transferred within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. The Ordinary Shares have not been and will not be approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.

In connection with the Placing, Numis Securities Limited and any of its affiliates, acting as investors for their own accounts, may subscribe for or purchase Ordinary Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Ordinary Shares and other securities of the Company or related investments in connection with the Placing or otherwise. Accordingly, references in the Admission Document to the Ordinary Shares being offered, subscribed, acquired, placed or otherwise dealt in should be read as including any offer to, or subscription, acquisition, placing or dealing by Numis Securities Limited and any of its affiliates acting as investors for their own accounts. In addition, Numis Securities Limited or its affiliates may enter into financing arrangements and swaps in connection with which it or its affiliates may from time to time acquire, hold or dispose of Ordinary Shares. Numis Securities Limited has no intention to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

Numis Securities Limited which is authorised and regulated by the Financial Conduct Authority in the United Kingdom is acting exclusively for the Company and no one else in connection with the Placing and Admission, and Numis Securities Limited will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing and Admission or any other matters referred to in this announcement.

Neither Numis Securities Limited, nor any of its subsidiary undertakings, affiliates or any of its directors, officers, employees, advisers, agents or any other person accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions contained in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith and any liability therefore is expressly disclaimed.

The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance, and persons needing advice should consult an independent financial adviser.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQXLBLZEFEBBB
Date   Source Headline
25th Aug 20227:00 amRNSTransaction in Own Shares
24th Aug 20227:00 amRNSTransaction in Own Shares
23rd Aug 20227:00 amRNSTransaction in Own Shares
22nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:36 pmRNSPrice Monitoring Extension
22nd Aug 20227:00 amRNSTransaction in Own Shares
19th Aug 20227:00 amRNSTransaction in Own Shares
18th Aug 20227:00 amRNSTransaction in Own Shares and Major Shareholding
12th Aug 20227:00 amRNSTransaction in Own Shares
11th Aug 20227:00 amRNSTransaction in Own Shares
10th Aug 20227:00 amRNSTransaction in Own Shares
9th Aug 20227:00 amRNSTransaction in Own Shares
8th Aug 20227:00 amRNSTransaction in Own Shares
3rd Aug 20227:00 amRNSTransaction in Own Shares
2nd Aug 20227:00 amRNSTransaction in Own Shares
29th Jul 20227:00 amRNSShare Buyback Programme
26th Jul 20227:00 amRNSTrading Update
29th Jun 20227:00 amRNSTrading Update
20th May 20222:05 pmRNSSecond Price Monitoring Extn
20th May 20222:00 pmRNSPrice Monitoring Extension
20th May 202212:33 pmRNSDirector Dealing
17th May 20227:00 amRNSInterim Results
8th Mar 202212:43 pmRNSResult of AGM
11th Feb 20228:22 amRNSTransfer of treasury shares, PDMR dealing & TVR
26th Jan 202210:34 amRNSHolding(s) in Company
17th Jan 20224:36 pmRNSPrice Monitoring Extension
11th Jan 20227:00 amRNSFinal Results
10th Jan 20224:41 pmRNSSecond Price Monitoring Extn
10th Jan 20224:35 pmRNSPrice Monitoring Extension
15th Nov 20212:05 pmRNSSecond Price Monitoring Extn
15th Nov 20212:00 pmRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSFurther Trading Update
19th Oct 20212:06 pmRNSSecond Price Monitoring Extn
19th Oct 20212:00 pmRNSPrice Monitoring Extension
13th Oct 202111:05 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSFull Year Trading Update
1st Jun 20217:00 amRNSChange of Adviser
28th May 20213:59 pmRNSDirectors’ Disclosure
21st May 20217:00 amRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSInterim Results
1st Apr 20217:00 amRNSResults of AGM
8th Mar 20217:00 amRNSDirectorate Appointment
8th Mar 20217:00 amRNSFinal Results
22nd Feb 20217:00 amRNSBoard Change
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 202111:06 amRNSDate of Final Results
26th Nov 202011:16 amRNSHolding(s) in Company
26th Nov 202011:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.